Radiesse® dermal filler incorporates our patented formulation of CaHA microspheres suspended in a gel carrier and is designed to provide satisfying, long-lasting, cost-effective and safe aesthetic benefits for patients. The product’s unique calcium-based microsphere technology, along with the proprietary gel technology, helps to restore volume and promotes the growth of the body’s own collagen, providing lasting, but not permanent, augmentation. Radiesse® dermal filler is the only dermal-filler in the United States with two FDA-approved facial indications.
Radiesse® dermal filler is indicated for the correction of moderate to severe folds and wrinkles, such as nasolabial folds, as well as for facial lipoatrophy, or facial fat loss, in patients with human immunodeficiency virus, or HIV.
Learn more about Radiesse® dermal filler in the U.S. for folds and wrinkles at www.radiesse.com
Learn more about how Radiesse® dermal filler may be able to help someone with HIV associated Facial Lipoatrophy at www.radiesse-fl.com
Learn more about Radiesse® dermal filler internationally, including approval status and indications at www.radiesse.com/worldwide
Please Note: these links are to external sites and will open another browser window.